我們已在上線! 進一步了解
PAHC圖示

Phibro Animal Health

38.82 USD
+0.84
2.21%
收盤時 已更新 10月16日 下午4:00 EDT
盤前交易
盤後交易
38.82
0.00
0%
1天
2.21%
5天
1.41%
1個月
9.97%
3個月
12.46%
6個月
-27.95%
今年迄今
4.08%
1年
0.65%
5年
78.48%
10年
55.97%
 

關於: Phibro Animal Health Corp is a world-wide diversified animal health and mineral nutrition company. It strive to be a trusted partner with livestock producers, farmers, veterinarians and consumers who raise and care for farm and companion animals by providing solutions to help them maintain and enhance the health of their animals. It develop, manufacture and market products for food animals including poultry, beef and dairy cattle, swine, aquaculture and dogs. It has three segments Animal Health, Mineral Nutrition, and Performance Products. Majority of revenue comes from Animal Health segment. Animal health products are anti-bacterials, anticoccidials, nutritional specialty products, and vaccines, and vaccine adjuvants that help improve the animal's health.

員工: 2,605

新聞

正面
中性
負面
市場情緒 3個月
正面 55.6%
中性 40.7%
負面 3.7%
中性
Zacks Investment Research
8 天前
Is it the Right Time to Add Phibro Stock to Your Portfolio?
PAHC's Animal Health gains from MFA, vaccine and mineral nutrition growth, but tariffs, costs and currency swings remain key risks to its outlook.
Is it the Right Time to Add Phibro Stock to Your Portfolio?
正面
Zacks Investment Research
11 天前
PAHC vs. HAE: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Haemonetics (HAE). But which of these two stocks presents investors with the better value opportunity right now?
PAHC vs. HAE: Which Stock Is the Better Value Option?
負面
Zacks Investment Research
21 天前
Why Is Phibro (PAHC) Down 6.7% Since Last Earnings Report?
Phibro (PAHC) reported earnings 30 days ago. What's next for the stock?
Why Is Phibro (PAHC) Down 6.7% Since Last Earnings Report?
正面
Zacks Investment Research
25 天前
Best Momentum Stocks to Buy for September 21st
SEI, SDRL and PAHC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 21st, 2026.
Best Momentum Stocks to Buy for September 21st
正面
Zacks Investment Research
28 天前
PAHC vs. HAE: Which Stock Should Value Investors Buy Now?
Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Haemonetics (HAE). But which of these two stocks presents investors with the better value opportunity right now?
PAHC vs. HAE: Which Stock Should Value Investors Buy Now?
正面
Zacks Investment Research
29 天前
Phibro Animal Health (PAHC) is a Top-Ranked Value Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Phibro Animal Health (PAHC) is a Top-Ranked Value Stock: Should You Buy?
正面
Zacks Investment Research
上個月
4 Stocks With Strong Interest Coverage to Buy as Yields Rise
DiamondRock Hospitality, Vertiv, Mueller Water Products and Phibro Animal Health stand out for strong interest coverage as Treasury yields rise.
4 Stocks With Strong Interest Coverage to Buy as Yields Rise
正面
Zacks Investment Research
上個月
Does Phibro (PAHC) Have the Potential to Rally 25.77% as Wall Street Analysts Expect?
The average of price targets set by Wall Street analysts indicates a potential upside of 25.8% in Phibro (PAHC). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Does Phibro (PAHC) Have the Potential to Rally 25.77% as Wall Street Analysts Expect?
正面
Zacks Investment Research
上個月
Why Phibro Animal Health (PAHC) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Phibro Animal Health (PAHC) is a Top Momentum Stock for the Long-Term
中性
Business Wire
上個月
Phibro Animal Health Corporation to Participate in Morgan Stanley Annual Global Healthcare Conference
TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Morgan Stanley Annual Global Healthcare Conference. President & Chief Executive Officer, Daniel Bendheim; Chief Operating Officer, Larry Miller; and Chief Financial Officer, Glenn David will address financial analysts and investors on Tuesday, September 15, 2026, at 1:05 PM ET at New York Marriott Marquis in New York. The live audio presentation will be available on the.
Phibro Animal Health Corporation to Participate in Morgan Stanley Annual Global Healthcare Conference
價格圖表採用Lightweight Charts™實作